Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2006 Mar 1;22(3):263-6.
doi: 10.1016/s0828-282x(06)70908-4.

Nonheart failure-associated elevation of amino terminal pro-brain natriuretic peptide in the setting of sepsis

Simona L Bar  1 , Elizabeth Swiggum, Lynn Straatman, Andrew Ignaszewski
Affiliations
Case Reports

Nonheart failure-associated elevation of amino terminal pro-brain natriuretic peptide in the setting of sepsis

Simona L Bar et al. Can J Cardiol. .

Abstract
in English, French

In addition to its importance in clinical assessment, N-terminal pro-brain natriuretic peptide (NT pro-BNP) is a valuable marker for evaluation of treatment and prognosis of heart failure. However, there are situations where NT pro-BNP is not related to myocardial dysfunction. Two cases of sepsis with markedly elevated NT pro-BNP levels that are not indicative of depressed myocardial function are described.

Outre son importance dans l’évaluation clinique, le pro-peptide natriurétique cérébral N-terminal (NT pro-BNP) est un marqueur valable d’évaluation du traitement et un pronostic d’insuffisance cardiaque. Cependant, dans certaines situations, le NT pro-BNP n’est pas relié à une dysfonction myocardique. Deux cas de sepsie accompagnés de taux manifestement élevés de NT pro-BNP non indicatifs d’une fonction myocardique déprimée sont décrits.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Waisbren BA. Bacteremia due to Gram-negative bacilli other than the Salmonella: A clinical and therapeutic study. AMA Arch Internal Med. 1951;88:467–88. - PubMed
    1. Charpentier J, Luyt CE, Fulla Y, et al. Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med. 2004;32:660–5. - PubMed
    1. de Groote P, Dagorn J, Soudan B, Lamblin N, McFadden E, Bauters C. B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure. J Am Coll Cardiol. 2004;43:1584–9. - PubMed
    1. Harrison A, Morrison LK, Krishnaswamy P, et al. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med. 2002;39:131–8. - PubMed
    1. Koglin J, Pehlivanli S, Schwaiblmair M, Vogeser M, Cremer P, vonScheidt W. Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol. 2001;38:1934–41. - PubMed

Publication types